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Abstract
Background
Non-specific low back pain (NSLBP) is the most prevalent musculoskeletal condition in west-
ern countries and is associated with persistent disability and high consumption of health care
resources. NSLBP patients first seek primary health care services but the outcomes are
often uncertain. This study aimed to examine the clinical course of the outcomes and to iden-
tify prognostic indicators for poor outcomes in NSLBP patients who consulted primary care.
Methods
A prospective cohort study of 115 patients seeking treatment for NSLBP in primary care
was conducted. Participants were consecutively recruited by their General Practitioners
(GPs) and then assessed at baseline and 2 and 6 months later. Baseline assessment
included socio-demographic and clinical data, psychosocial factors, pain, disability, and
health related quality of life (HRQoL). Pain, disability, HRQoL and global perception of
change were also assessed at 2 and 6-months’ follow-up. In addition, information regarding
the GP’ practice was collected. Poor outcomes were determined according to the cut-off
point used to define a persistent disabling condition and the minimal important change
established for disability, pain and for global perception of change. The relationship between
variables on baseline and poor outcomes was modulated through binary logistic regression
analysis. The significance of associations was evaluated at� 0.05 p-value with 95% confi-
dence intervals (CI) and adjusted odds ratios (AOR).
Results
110 (94.8%) and 104 (89.7%) participants completed the follow-up assessment at 2 and 6
months, respectively. The mean age (±SD) was 48.06 ± 11.41, with 53.9%, (N = 62)
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reporting an acute presentation of NSLBP. Six months after GP consultation, 53.8% (N =
56) of the participants reported a persistent disabling condition. An “LBP episode of less
than 12 weeks” [AOR: 0.26; 95% CI (0.10, 0.65); AOR: 0.34; 95% CI (0.14, 0.81); AOR:
0.21; 95% CI (0.09, 0.53)],”maladaptive psychosocial factors” [AOR: 2.06; 95% CI (1.40,
3.04); AOR: 1.82; 95% CI (1.27, 2.59); AOR: 1.72; 95% CI (1.20, 2.47)] were significantly
associated with poor outcomes on disability, pain and global perception of change, respec-
tively. Besides these factors, being employed reduces the chances of poor outcomes on dis-
ability [AOR 0.31; 95% CI (0.11, 0.92)].
Conclusions
A large proportion of LBP patients seeking primary health care reported poor outcomes 6
months after GP consultation. Patients who report chronic LBP, maladaptive psychosocial
factors and are unemployed have a significant increase in the risk of poor outcome. These
findings suggest the need of implementing effective models of care able to provide early
screening and appropriate treatment to those at greatest risk of a poor outcome.
Trial registration
Current Controlled Trials NCT04046874 (August 6, 2019). Retrospectively registered.
Introduction
Non-specific low back pain (NSLBP) is one of the most common health problems in society
and causes considerable disability, work absenteeism, and use of health services [1,2]. A sys-
tematic analysis for the Global Burden of Disease (GBD) reported that NSLBP stands out as
the leading musculoskeletal disorder because of a combination of high prevalence and greater
disability associated with this health state [2,3]. In Portugal, LBP is the most prevalent rheu-
matic and musculoskeletal disease affecting a large proportion of the population (26.4%) with
significant costs for society and a large impact on disability, perceived health and quality of life
for the individual [4].
In contrast with this burdensome scenario, episodes of acute NSLBP (pain of less than six
weeks) have good prognosis. Findings of a prognostic systematic review and meta-analysis
indicate that a marked reduction in mean pain and disability is expected in the first 6–8 weeks
[5]. Beyond that time frame period, improvement slows and the probability of developing a
persistent disabling back pain condition improves for approximately 40% of the patients [6].
Some of these patients will recover while others will develop a persistent severe LBP condition.
The latter account for most of the social and health costs associated with this condition [7–11].
Probably due to the rapid improvement from an episode of LBP, a large proportion of peo-
ple do not seek care. A review of ten population-based studies reported a pooled prevalence of
care seeking of 58% [12], most commonly requested by women, individuals with poor general
health, and with more disabling or more painful episodes [12,13]. These patients first seek pri-
mary health care services where the outcomes are often uncertain or differ widely between
studies [14]. In studies focused on the course of pain, functional status, or mixed outcomes
conducted in primary care settings, the proportion of patients with a poor outcome at 6
months ranged from 2% to 48% [14–17]. This wide range regarding the probability of achiev-
ing a poor outcome is possibly due to differences in study populations (acute/ sub-acute or
PLOS ONE Prognostic indicators for poor outcomes in low back pain patients
PLOS ONE | https://doi.org/10.1371/journal.pone.0229265 March 27, 2020 2 / 15
covers all the planned activities for this study
including, the design of the study, data collection,
data analysis and interpretation and the writing of
this manuscript.The funder did not play any role in
the study design, data collection and analysis,
decision to publish, or preparation of this
manuscript.
Competing interests: The authors have declared
that no competing interests exist.
Abbreviations: NLBP, Non-specific low back pain;
HRQoL, Health-related quality of life; GP, General
Practitioners; CI, confidence intervals; AOR,
adjusted odds ratios; LBP, Low back pain; GBD,
Global Burden of Disease; STROBE, STrengthening
the Reporting of OBservational studies in
Epidemiology; RA, research assistant; NPRS,
Numeric Pain Rating scale; SBST, Start back
screening tool; RMDQ, Roland Morris disability
questionnaire; EQ-5D-3L, EuroQol 5-dimension 3-
level; GPES, Global Perceived Effect Scale; ICC,
intraclass correlation coefficients; MIC, minimal
important change; ORs, Odds ratios; AUC, area
under the receiver operating characteristic curve;
SD, Standard deviation; NSAIDs, Nonsteroidal anti-
inflammatory drugs.
chronic), the timeframe used for recruitment (e.g. first two weeks after the onset) and the crite-
ria used to define a clinically important improvement or recovery [13]. However, and overall,
these results suggest that for many LBP patients ongoing symptoms and residual disability
may be common.
The inconsistent results found for the course of outcomes are extensible for prognostic
indicators. A review of prognostic indicators concludes that the reporting of the strength of
association was very inconsistent among the studies [6]. Indicators such as body mass index,
age, symptom duration, distress, maladaptive pain behaviors, higher depressive symptoms,
previous episodes of low back pain, higher intake pain intensity and functional disability, gen-
eral health status and job satisfaction are often reported as important prognostic indicators for
the development of persistent low back pain [6, 13, 17–25]. However, most of the prospective
studies have been carried out on patients with recurrent acute and sub-acute LBP [14,15, 17,
21–23]. NSLBP patients seeking primary care for LBP treatment are a mixture of acute, sub-
acute and chronic pain patients and few studies have explored the course of outcomes and
prognostic indicators in mixed samples of LBP patients, in particular in patients who consult
primary care.
Since most of the LBP patients first use primary health care services, and given the projected
increases in such a burden as identified by the GBD study [26] are likely to add significantly to
the primary care workload, the early identification of prognostic indicators for patients at risk
for developing persistent and disabling symptoms might be crucial to identify which patients
will most likely benefit from early intervention to decrease the likelihood of poor outcomes
and prevent the development of a persistent and disabling LBP condition. The aims of this
study were to examine the clinical course of pain, disability, health related quality of life and
global perception of change, and to identify prognostic indicators for poor outcomes in
patients seeking primary care for an episode of NSLBP of any duration.
Materials and methods
A cohort of 115 patients seeking treatment for active symptoms of low back, with or without
leg pain, of any duration, was consecutively recruited from 7 different primary care units in
Portugal during a 7 months period (February to September 2018). Ethical approval was
granted by the Ethics Committee of Regional Health Administration of Lisbon and Tagus val-
ley (ARSLVT) (REF 3562/CES/2018). All the participants received oral and written informa-
tion about the study and provided their written informed consent prior to participating. The
study followed the STROBE guidelines for reporting observational studies [27,28].
All patients were referred for the study by their GP and screened for eligibility by a research
assistant. GPs were encouraged to assess and treat their patients as usual and make all the refer-
rals they think are appropriate for their patients. Potential participants were informed that par-
ticipating in this study would not dictate the treatment they received for their LBP.
Participants were eligible if they were aged between 18 and 65 years, able to read and speak
the Portuguese language and have a diagnosis of NSLBP (with or without leg pain and of any
duration), defined as pain limited to the region between the lower margins of the 12th rib and
the gluteal folds” [1, 29–31]. They were excluded if they have clinical signs of infection, tumor,
osteoporosis, fracture, structural deformity, inflammatory disorder, radicular syndrome, or
cauda equine syndrome, if they have severe depression or other psychiatric condition, if they
are pregnant, or if they have undergone back surgery in the prior 6 months.
Immediately following the GP consultation, the research assistant assessed the enrolled par-
ticipants at baseline and then at 2 and 6 months follow-up. This time periods were chosen
given the marked improvement that is expected in the first 6 to 8 weeks following a new
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episode/ exacerbation of a prior condition of LBP and because little additional change has
been shown to occur beyond 6 months [32].
Baseline assessment included a socio-demographic and clinical questionnaire, the Numeric
Pain Rating Scale (NPRS), and the Portuguese versions of the Start Back Screening Tool
(SBST), Roland Morris Disability Questionnaire (RMDQ), and the EuroQol five-dimension
(EQ-5D, 3L). Following this baseline assessment, participants were contacted by telephone by
the same research assistant at 2 and 6 months follow-ups and were reassessed with the NPRS,
RMDQ-PT and the EQ-5D. A Global Perceived Effect Scale (GPES) to assess patient percep-
tion of change of their back condition was added in the follow-up reassessments. In addition,
and to characterize the diagnostic procedures/ treatments received in these practices, informa-
tion regarding the requested imaging tests, medication prescribed, sickness certificates and the
referral to physiotherapy or to other medical specialities or services was collected from the par-
ticipants’ health electronic records.
Sample size
The sample size calculations were performed according to the general rule for dichotomous
outcomes, which suggests that 10 events are required per each prognostic association tested
[33]. In the present study, a total of 10 prognostic factors were included. Given the use of dif-
ferent poor outcome criteria an estimation of the poor outcome rate is difficult. Thus, the sam-
ple size estimation was based on the assumption of an expected 50% of probability of poor
outcomes, at least 5 candidate variables on the multivariable analysis, and an estimated loss of
follow-up of 15%. These assumptions generated a sample size of a minimum of 112
participants.
Prognostic indicators
Potential prognostic indicators were identified via a literature search [6, 13, 17–25]. They
included: age (in years), gender, working status (active/ not working), referred leg pain (yes/
no), NSLBP pain medication (yes/ no), and current episode duration (acute/ sub-acute < 3
months; and chronic� 3 months), maladaptive psychosocial factors, current pain intensity,
disability and HRQoL.
The Keele Start Back Screening Tool (SBST) is a screening tool aimed to subgroup patients
with regard to their risk of developing persistent LBP in primary care settings [34]. The psy-
chosocial subscale score of the Portuguese version of the SBST (SBST-PT) was used to assess
the presence of maladaptive psychosocial factors [34]. This subscale screens for modifiable pre-
dictors of persistent disabling back pain, including, fear avoidance, anxiety, pessimistic patient
expectations, low mood and how much the patient is bothered by their pain, providing a psy-
chosocial distress score [34].
Disability was measured with the Portuguese version of the RMDQ. The RMDQ consists of
24 items that assesses the functional status over the past 24 hours in patients with LBP [35].
Each answer can be scored “0” or “1”, thus leaving a range of scores from 0 to 24, with higher
scores indicating higher disability. The RMDQ has shown good validity and test–retest reli-
ability with reported intraclass correlation coefficients (ICC) of 0.8 or more [35–37].
Pain intensity was measured with a numerical pain rating scale (NPRS). Participants were
asked to rate the intensity of their current pain on a scale of 0 (“no pain”) to 10 (“worst possi-
ble pain”) [38]. The NPRS has proven to be valid and reliable in patients with LBP pain
[39,40].
Health Related Quality of Life (HRQoL) was measured with the Portuguese version of the
EQ5D, 3L [41]. The index of the health status of the individual, which varies from a higher
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value of "1" (corresponding to the best possible health), and "0" (death) [41,42], was calculated
to assesse HRQoL based on status in 5 dimensions: mobility, self-care, usual activities, pain
discomfort and anxiety/depression, each with 3 levels of severity (0 = ‘no problem’, 1 = ‘mod-
erate problem’, or 2 = ‘extreme problem). The weight applied to the severity states was based
on the Portuguese valuation study of the EQ-5D,3L [43].
The overall perceived effect of treatment was measured with the GPES. GPES is a transition
scale designed to assess the patients’ perception of change of their back condition [44,45]. The
GPES ranged from -5 (“vastly worse”) to +5 (“completely recovered”). The Portuguese version
of the GPES (GPES-PT) showed adequate test-retest reliability, validity and responsiveness
[46]. A score of�3 has been proposed as the value that best discriminate between participants
who have improved from participants who remained the same [46].
Poor outcomes
Patient poor outcomes were determined at 2 and 6-months follow-ups, according to two dif-
ferent criteria. The primary outcome considered in this study was “persistent disabling low
back pain” defined as the presence of a score of�7 on the RMDQ. This score was previously
used to classify patients with a persisting and disability NSLBP condition [34]. Accordingly,
participants in the 2 and/ or 6-months follow-ups that reported a RMDQ score�7 were classi-
fied as having a persistent and disabling NSLBP condition. The secondary outcome criteria
used to define a poor outcome status was the minimal important change (MIC) used to catego-
rize patient’s improvement/ no improvement regarding disability, pain intensity and percep-
tion of overall change. Previous studies have established the MIC for the RMDQ and NPRS at
a reduction of�30% from their baseline score [47], and a GPES score of�3 points at the fol-
low-ups [46]. The 30% improvement on the RMDQ/ NPRS was calculated as follows: [(base-
line RMDQ/ NPRS score- final RMDQ/ NPRS score)/(baseline RMDQ/ NPRS score)] X 100.
For both classifications ‘‘no improvement” in this study was used to indicate ‘‘poor outcome.”
Data analysis
All statistical analyses were carried out using the SPSS version 24.0 (SPSS Inc., Chicago, IL).
Descriptive statistics were computed to summarize the participants’ characteristics and the
course of clinical outcomes: pain, disability, and HRQoL. Changes between baseline and fol-
low-ups of disability, pain intensity, and HRQoL scores were first checked for normality (Kol-
mogorov- Smirnov test) and then analyzed using an ANOVA Friedman test (given the non-
normality of the data). Pairwise comparisons were performed with a Bonferroni correction for
multiple comparisons [48].
Poor outcome rates were determined from the percentage of those that met the no
improvement criterion (poor outcomes) compared to those that meet the improvement crite-
rion. Binary logistic regression models were constructed using baseline variables as potential
prognostic factors for poor outcomes. In the bivariate analysis, variables with a significance
level of less than 0.20 progressed to the next phase of modeling [49,50]. Separate multivariate
models, using backward conditional elimination method, were then built for poor outcomes
status (NPRS/RMDQ/ GRCS of less than MIC; RMDQ score of�7), at 2 and 6 months follow-
up. Odds ratios (ORs) and corresponding 95% confidence intervals (CIs) were calculated for
all variables in the bivariate and multivariate analysis. All variables remaining in the final
model had an OR with a p value less than 0.05.
Lastly, the ability of the final model to discriminate between participants who remained the
same/ worse from participants who have improved was calculated from the area under the
receiver operating characteristic curve (AUC) using the different MICs and the persistent and
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disabling condition values as the external criterion. An AUC of 0.5 indicates no discrimination
and 0.9, excellent discrimination [50].
Results
Of the 119 NSLBP patients referred to the study, 115 completed the baseline assessment (Fig
1). Of the 115 enrolled NSLBP patients, 110 completed the 2 months follow-up (5 dropouts)
and 104 the 6-month’s follow-up (6 drop outs). Reasons for withdrawal were exclusively
related with the impossibility to contact the participants.
Table 1 details the baseline characteristics of these 115 patients. The mean age (±SD) was
48.06 ± 11.41, and they were predominantly female (56%) and employed (76.7%). Approxi-
mately half of the participants (53.4%) were acute presentations of NSLBP with a mean (±SD)
disability score (RMDQ) of 12.6 (±5.9) and mean pain intensity score (NPRS) of 5.4 (±2.56).
Primary care management
In terms of the diagnostic management strategies used by GP, 56.9% of the participants were
referred for imaging tests (35.7% plain x-rays and 14.8% computerized tomography) and 4.6%
for other medical specialities consultations. Medication was the main treatment strategy used
(83.5%), with an average of two medications prescribed per person. Nonsteroidal anti-inflamma-
tory drugs (NSAIDs) (81.4%) and muscle relaxants (60.8%) followed by weak opioids (19.6%)
were the types of medication most often chosen by the GPs. Only 8.3% of patients having been
referred for physiotherapy and 32.6% of the employed participants received a sickness certificate.
Course of outcomes
On average and comparing to baseline data, disability score (RMDQ) improved by 3.4 points
at 2 months and by 4.2 points at 6 months. Pain intensity score improved by 1.5 points at 2
months and by 2.1 points at 6 months, and HRQoL index scores improved by 0.17 and 0.12
points, at 2 and 6-month follow-ups, respectively (Table 2). The results of the Friedman test
Fig 1. Study flowchart.
https://doi.org/10.1371/journal.pone.0229265.g001
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shown statistically significant improvements in the course of disability (χ2(2) = 25.164, p<
0.005), pain intensity (χ2(2) = 25.099, p< 0.005), and HRQoL (χ2(2) = 27.638, p� 0.005) dur-
ing the 6-month period. Post hoc analysis revealed statistically significant differences in the 3
outcomes from baseline to 2-month follow-up and from baseline to 6-month follow-up, but
not from 2 months and 6-month follow-ups (Table 2).
Despite statistical significant improvements at 2 months follow-up, approximately half of
the patients did not reach the established recovery criteria for disability and pain (50.9% in dis-
ability and 50% in pain intensity), and 47.3% of the participants did not perceived any change
in their condition or feel the same or worse (Table 3). At the 6 months follow-up the percent-
age of participants with poor outcomes decreased to 42.3% for pain, but remained nearly con-
stant for disability (49%) and for perception of overall improvement regarding patient´s back
condition (46.2%). Six months after GP appointment 53.8% of the participants reported
RMDQ scores compatible with persistent disability (RMDQ� 7) (Table 3).
Prognostic factors
Tables 4 and 5 presents the results of the multiple logistic regression analyses for poor out-
comes at 2 and 6 months after the initial GP consultation. Overall, pain duration and the
Table 1. Baseline characteristics of study population (n = 115).
Variables, descriptive measures Categories Mean (SD) or Frequency
Age (years), mean ± SDa 48.06 (±11.41)
Gender, no (%)
Male 50 (43.5%)
Female 65 (56.5%)
Work status, no (%)
Active 89 (77.4%)
Not working 26 (22.6%)
Episode duration, no (%)
Acute/ sub-acute (<3 months) 62 (53.9%)
Chronic (�3 months) 53 (46.1%)
Referred leg pain, no (%)
Yes 76 (66.1%)
No 39 (33.9%)
Pain medication (at the moment), no (%)
Yes 66 (57.4%)
No 49 (42.6%)
SBSTb overall score, mean ± SD 5.4 (± 2.1)
SBSTb Psychosocial subscale (Q5-9), mean ± SD 2.8 (± 1.3)
Pain intensity (NPRSc 0–10), mean ± SD 5.4 (± 2.6)
Disability (RMDQd 0–24), mean ± SD 12.6 (± 5.9)
HRQoLe (EQ5D,3Lf Index), mean ± SD 0.44 (± 0.23)
Values are numbers (percentages) unless stated otherwise.
a Standard deviation
b Start Back Screening Tool
c Numeric Pain Rating Scale
d Roland Morris Disability Questionnaire
e Health Related Quality of Life
f EuroQuol 5D, 3L.
https://doi.org/10.1371/journal.pone.0229265.t001
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presence of maladaptive psychosocial factors were the two independent baseline predictors
consistently associated with poor outcome at 2 and 6 months.
Persistent disabling symptoms at 2 and 6 months (RMDQ score of�7) were predominantly
associated with the duration of the LBP episode and the presence of maladaptive psychosocial
factors. Participants with a LBP episode of less than 3 months had a reduced OR for persistence
of symptoms at 2 and 6 months, respectively (OR 0.16 95%CI 0.05 to 0.51, p�0.05; OR 0.29
95%CI 0.10 to 0.83, p�0.05). In contraire, high scores at the baseline on the SBST psychosocial
sub score improve the chance of developing a persistent pain and disability condition (OR 1.77
95% CI 1.11 to 2.82, p�0.05; OR 1.94 CI 1.23 to 3.06, p�0.01), at 2 and 6 months following GP
consultation, respectively. Additionally, being non-employed and having higher disability
scores at baseline improves the chance of developing a persistent pain and disability condition
6 months following this consultation (Table 5). Discrimination of both models (2 and 6
months) was good, with an AUC of 0.86 and 0.83, respectively.
Regarding the MIC criteria, two months after GP’s consultation, and after adjustment,
three independent baseline predictors improve the odds of poor outcome, regarding disability,
pain and perception of overall change: High scores on the SBST psychosocial subscale (OR:
1.65, 95% CI 1.13–2.40, for pain; OR: 1.61, 95% CI 1.15–2.24, for disability); a LBP episode of
more than 3 months duration (OR: 1.71, 95% CI 1.33–1.88, for pain; OR: 1.76, 95% CI 1.43–
1.89, for disability), and high levels of pain intensity at baseline for pain (OR: 1.26, 95% CI
1.09–1.39) (Table 4). The discrimination of the different models was acceptable, with an AUC
ranging between 0.72 and 0.73.
At 6-months, and after adjustment to significant baseline variables, participants with a LBP
episode of less than 12 weeks reduced their probability of poor outcomes on disability, pain
Table 2. Course of outcome scores of the NSLBP patients.
Self-reported Measures/ Outcome Criteria Baseline (n = 115) 2 Months (n = 110) p 6 Months (n = 104) p
Disability (RMDQ 1 0–24) (median) 13 8 < 0.005 8 < 0.005
Pain intensity (NPRS 2 0–10) (median) 6 4 < 0.005 3 < 0.005
HRQoL (EQ5D 3 Index) (median) 0.45 0.59 < 0.005 0.59 < 0.005
1 RMDQ-Roland Morris Disability Questionnaire
2 NPRS- Numeric Pain Rating Scale
3 EQ5D- EuroQuol 5D, 3L.
https://doi.org/10.1371/journal.pone.0229265.t002
Table 3. Proportion of patients with poor outcomes according to the different criteria used.
Self-reported Measures/ Outcome Criteria 2 Months
(n = 110)
6 Months
(n = 104)
Participants with RMDQ 1�7 64 (58.2%) 56 (53.8%)
Participants with poor outcome on disability (improvement of < 30%
RMDQ)
56 (50.9%) 51 (49%)
Participants with poor outcome on pain intensity (improvement of < 30%
NPRS 2)
55 (50%) 44 (42.3%)
Participants not perceived a meaningful change in their condition (score
of < 3 GPES3)
52 (47.3%) 48 (46.2%)
Values are numbers (percentages)
1 RMDQ- Roland Morris Disability Questionnaire
2 NPRS- Numeric Pain Rating Scale
3 GPES- Global Perceived Effect Scale.
https://doi.org/10.1371/journal.pone.0229265.t003
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and global perception of change (OR: 0.26 95%CI 0.10 to 0.65, p� 0.01; OR: 0.34 95%CI 0.14
to 0.81, p�0.05, OR: 0.21 95%CI 0.09 to 0.53, p� 0.01, respectively). The presence of”maladap-
tive psychosocial factors” (higher psychosocial sub score), however, increased the odds of poor
outcomes for disability, pain and global perception of change (OR 2.06 95%CI 1.40 to 3.04, p�
0.01; 1.82 95%CI 1.27 to 2.59, p� 0.01; 1.72 95%CI 1.20 to 2.47, p�0.05, respectively). Besides
these factors, being employed reduces the chances of poor outcomes on disability (OR 0.31
95%CI 0.11 to 0.92, p�0.05) (Table 4). The discrimination of the different models was accept-
able, with an AUC ranging between 0.73 and 0.78.
Discussion
This study presents the course of the outcomes for patients consulting primary care for an epi-
sode of NSLBP. Additionally, it identifies factors associated with the achievement of poor out-
comes. Although data was generated from 7 primary care units of a specific health care center,
Table 4. ORs (95% Confidence Intervals) for the associations between prognostic indicators and poor outcome status at 2 Months follow-up (n = 110).
Prognostic indicators RMDQ1 �7 N = 64 MIC2-RMDQ <30% N = 56 MIC-NPRS3 <30% N = 55 MIC-GPES4�3 N = 52
Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted
Sociodemographic variables
Age (yr) continuous 1.0 (0.97–1.04) 1.03 (0.99–
1.06)�
1.03 (0.99–
1.07)�
1.0 (0.97–1.03)
Gender (ref female) 0.85 (0.39–
1.82)
0.70 (0.33–
1.48)
0.54 (0.25–
1.15)�
0.68 (0.32–
1.44)
Work status (ref not working) 0.73 (0.29–
1.84)
0.50 (0.20–
1.26)�
0.31 (0.12–
0.81)��
0.31 (0.11–
0.86)��
0.78 (0.32–
1.91)
NSLBP characteristics
Duration of LBP episode (ref > 3
months)
0.60 (0.28–
1.30)�
0.16 (0.05–
0.51)��
0.30 (0.14–
0.65)��
0.25 (0.10–
0.58)���
0.34 (0.16–
0.74)��
0.36 (0.16–
0.82)��
0.36 (0.28–
1.52)�
0.29 (0.13–
0.67)��
Radiating leg pain (ref no) 2.52 (1.12–
5.67)
1.6 (0.72–3.53) 2.16 (0.96–
4.84)��
2.12 (0.94–
4.80)
LBP Pain medication (ref no) 1.15 (0.54–
2.47)
0.51 (0.24–
1.09)
1.15 (0.41–
3.24)
0.76 (0.27–
2.18)
Self-reported Measures
Psychosocial factors (SBST5
Psychosocial sub-score, 0–5)
1.43 (1.53–
3.27) ���
1.77 (1.11–
2.82)��
1.48 (1.09–
2.02)��
1.73 (1.22–
2.45)��
1.21 (0.90–
1.62)
1.61 (1.17–
2.21)��
1.72 (1.23–
2.40)��
Pain intensity (NPRS 0–10) 2.24 (1.19–
1.71)���
1.08 (0.93–
1.25)
0.85 (0.73–
0.99)��
0.84 (0.72–
0.99)��
1.02 (0.88–
1.18)
Disability (RMDQ, 0–24) 1.24 (1.14–
1.35)���
1.01 (0.95–
1.08)
0.99 (0.93–
1.05)
1.0 (0.95–1.07)
HRQoL (EQ5D6 Index, 0–1) 0.05 (0.01–
0.59)���
0.95 (0.18–
4.09)
4.19 (0.53–
33.2)�
0.66 (0.9–4.92)
Area Under de Curve (AUC) 0.86 (0.79–
0.93)
0.72 (0.63–
0.82)
0.73 (0.63–
0.82)
0.73 (0.64–
0.83)
�P<0.2
��P<0.05
���P<0.01.
1 RMDQ- Roland Morris Disability Questionnaire
2MIC—minimal important change
3 NPRS- Numeric Pain Rating Scale
4 GPES- Global Perceived Effect Scale
5 SBST–Start Back Screening Tool
6 EQ5D- EuroQuol 5D, 3L
https://doi.org/10.1371/journal.pone.0229265.t004
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comparison with data from a Portuguese population-based study and other primary care stud-
ies suggests that the participants in this study are similar to the Portuguese population with
LBP and patients searching for LBP primary care in other countries [4; 16]. Care seeking for a
LBP episode is more common in women, and in individuals with poor general health, and
with more disabling or more painful episodes [12,13].
The clinical course of disability, pain and HRQoL were favorable with statistical significant
differences during the follow-up period (p�0.05). However no additional significant change
has been shown to occur between 2 and 6 months. These results are consistent with previous
reports and confirm the common trend of early rapid improvement in symptoms that slow
down and reach a plateau 6 months after the start of treatment [6; 32].
This study’s findings indicated that 6-month after GP consultation approximately half of
the participants reported RMDQ scores compatible with the established definition of persis-
tent disability (RMDQ� 7). When considering the short-term outcomes, half of the NSLBP
Table 5. ORs (95% Confidence Intervals) for the associations between prognostic indicators and poor outcome status at 6 Months follow-up (n = 104).
Prognostic indicators RMDQ1�7 N = 56 MIC2-RMDQ <30% N = 51 MIC-NPRS3 <30% N = 44 MIC-GPES4 N = 48
Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted
Sociodemographic variables
Age (yr) continuous 1.03 (1.0–
1.07)�
1.04 (1.01–
1.08)��
1.04 (1.0–
1.08)�
1.03 (1.0–
1.07)�
Gender (ref female) 0.78 (0.35–
1.65)
0.48 (0.22–
1.07)�
0.48 (0.22–
1.08)
0.51 (0.23–
1.13)�
Work status (ref not working) 0.46 (0.18–
1.19)�
0.30 (0.09–
0.98)��
0.35 (0.14–
0.92)��
0.31 (0.11–
0.92)��
0.31 (0.12–
0.81)�
0.38 (0.15–
0.97)��
NSLBP characteristics
Duration of LBP episode (ref > 3
months)
0.58 (0.26–
1.26)�
0.29 (0.10–
0.83)��
0.33 (0.15–
0.74)���
0.26 (0.10–
0.65)���
0.42 (0.19–
0.93)��
0.34 (0.14–
0.81)��
0.26 (0.11–
0.58)���
0.21 (0.09–
0.53)���
Radiating leg pain (ref no) 4.45 (1.87–
10.6)���
1.88 (0.82–
4.27)�
1.48 (0.65–
3.40)
1.88 (0.82–
4.30)�
LBP Pain medication (ref no) 1.67 (0.76–
3.65)
1.01 (0.47–2.2) 0.73 (0.33–
1.60)
0.70 (0.32–
1.53)
Self-reported Measures
Psychosocial factors (SBST5
Psychosocial sub-score, 0–5)
2.24 (1.52–
3.31)���
1.94 (1.23–
3.06)���
1.79 (1.27–
2.53)���
2.06 (1.40–
3.04)���
1.72 (1.22–
2.42)��
1.82 (1.27–
2.59)���
1.52 (1.1–
2.1)��
1.72 (1.20–
2.47)��
Pain intensity (NPRS, 0–10) 1.26 (1.07–
1.49)��
1.09 (0.94–
1.27)
1.22 (1.03–
1.43)��
1.12 (1.02–
1.41)��
Disability (RMDQ, 0–24) 1.17 (1.08–
1.26)���
1.16 (1.05–
1.28)���
0.99 (0.93–
1.05)
1.02 (0.95–
1.09)
1.0 (0.93–1.07)
HRQoL (EQ5D6 Index, 0–1) 0.10 (0.01–
0.64)��
0.56 (0.29–
8.35)
0.64 (0.12–
3.49)
2.52 (0.45–
14.0)
Area Under de Curve (AUC) 0.83 (0.75–
0.91)
0.78 (0.69–
0.87)
0.73 (0.63–
0.83)
0.77 (0.68–
0.86)
�P<0.2
��P<0.05
���P<0.01.
1 RMDQ- Roland Morris Disability Questionnaire
2MIC—minimal important change
3 NPRS- Numeric Pain Rating Scale
4 GPES- Global Perceived Effect Scale
5 SBST–Start Back Screening Tool
6 EQ5D- EuroQuol 5D, 3L
https://doi.org/10.1371/journal.pone.0229265.t005
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patients did not reach the MIC criteria (>30% on NPRS and RMDQ), 38% of the patients
reported they felt the same or worse, and 76.4% had a poor HRQoL.
Comparisons of the course of outcomes are difficult since many differences exist in terms
of the LBP definition used, sample characteristics, length of follow-up or outcomes criteria.
For example, in an inception cohort of acute LBP, the cumulative probability of being pain
free or having no disability at 6 weeks, defined as being pain-free, or without disability sus-
tained for a whole month, was 39% and 55%, respectively [17]. By 12 weeks the probability
increases to 58% and 73%, respectively [17]. In another large cohort study [15] with 521 acute
LBP patients, where the authors used the criteria of “fully recovered”, assessed by a general per-
ceived recovery scale, at 6 months, only 19% reported that they weren’t “fully recovered”, nor
“much improved” (poor outcomes) and 22% had a RMDQ score of�7. In a randomized con-
trolled trial with mixed patient populations of LBP, including acute and chronic LBP partici-
pants and using the same MIC criteria used in this study for classifying the achievement of
poor outcomes (change of<30% from the baseline RMDQ score), 31% to 44% of the partici-
pants reported poor outcomes [16]. Thus, this study’s findings indicate a higher rate of poor
outcomes but reasons for this difference are difficult to find.
In this study, poor outcomes were consistently associated with a longer duration of the LBP
episode and with the presence of maladaptive psychosocial factors (p�0.05), after adjusting for
patient demographic and clinical characteristics. Odds ratios indicated that patients with an
episode of pain of less than 12 weeks have a decrease in their likelihood of achieving short-
term poor outcomes that vary from 64% to 83%. Moreover, the probability of poor outcomes
increases as the psychosocial score of the SBST-PT increases in a range that varies from 57% to
72%. These results suggest that an early identification of the presence of these factors and the
implementation of target evidence base interventions might be crucial to decrease the likeli-
hood of poor outcomes and prevent the development of a persistent and disabling LBP condi-
tion. Maladaptive psychosocial factors have previously been shown to be strong predictors of
poor outcomes [17,18], as well as predictors of chronicity and future disability [19,20] in acute
and chronic LBP cohorts. Addressing these factors in primary care at an early stage, before
they become well- established and more difficult to treat, could reduce the risk of developing a
persistent disabling LBP condition [16; 51].
Strengths and limitations
The aims of this study were to describe the current health care practice, to examine the clinical
course of the outcomes and to identify prognostic indicators for poor outcomes in NSLBP
patients who consulted primary care. It is worth noting that the findings of this study emerged
from the analysis of the practice in 7 primary care units of a specific health care center, which
may limit the generalizability of these findings.
It is also important to note that this study design does not assess the effectiveness of the cur-
rent health care practice. Although the characteristics of the current health care practice have
been recorded and have shown high order rates of imaging and sickness certificates and the
use of medication as the first line of treatment, with a small percentage of patients being
referred for physiotherapy, this information was based on the data available in the medical rec-
ords of the GP’s initial appointment. It is therefore possible that not all participants have fol-
lowed the recommendations of their GP and have decided to not take the prescribed
medication or follow other treatments. Therefore, we cannot make any inferences on whether
any particular treatment approaches implemented had an influence on outcome rates. Out-
come differences found between time points and improvement/non improvement rates could
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be attributable to the natural history of the condition, regression to the mean, non-specific or
specific aspects of the intervention.
The major strengths of this study are the pragmatic nature of this observational study, the
minimal loss to follow-up, the use of validated outcome measures, and the low risk of over-fit-
ting of the prediction models.
Conclusions
This study found that 6-months after consulting primary care for an NSLBP episode approxi-
mately half of the participants reported poor outcomes. Furthermore, no additional significant
change has been shown to occur between 2 and 6 months, suggesting that any improvement
occurs in the first 8 weeks after a LBP onset. Thereafter, the effective management of LBP
patients at the early stage of an LBP onset seems to be crucial for the prevention of the develop-
ment of a persistent disabling back pain condition.
In this study, poor outcomes were consistently associated with a longer duration of the LBP
episode and with the presence of maladaptive psychosocial factors. Thus, the early identifica-
tion of the presence of these factors and the implementation of target evidence base interven-
tions might be crucial to decrease the likelihood of poor outcomes and prevent the
development of a persistent and disabling LBP condition.
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